Prathap Reddy Basani

Prathap Reddy Basani

Auto-generated profile, based on publicly available information

Prathap Reddy Basani

Department of General Surgery, Father Colombo Institute of Medical Sciences, Warangal, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2026 in Archives of Breast Cancer
Verified
Journal Article
Open access
PDF file
DEDeepthi Enumula
Deepthi Enumula
VNVanitha Rani Nagasubramanian
Vanitha Rani Nagasubramanian
SAShyam Sunder Anchuri
Shyam Sunder Anchuri
BDBhawna Dev
Bhawna Dev
PBPrathap Reddy Basani
Prathap Reddy Basani
SMShabna Roupal Morais
Shabna Roupal Morais
Background: Breast cancer is prevalent among women globally and is linked to metabolic syndrome (MetS). Adipokines are implicated in tumor development by influencing metabolic and inflammatory processes. This study evaluated serum adiponectin and leptin levels of breast cancer patients with MetS and their association with clinicopathological tumour characteristics. Methods: A case-control study was conducted in 150 females aged 35-70 years. Cases included 75 newly diagnosed breast cancer with MetS and controls were 75 with MeS matched for age and body mass index (BMI). Serum adiponectin and leptin levels were analysed by direct ELISA and the data using multivariate analysis, ANOVA/Kruskal–Wallis tests, and ROC curve analysis as appropriate. Results: The serum adiponectin levels were significantly lower (7.32 ± 2.54 ng/ml vs 8.67 ± 3.78 ng/ml; p =0.011) and leptin levels were significantly higher (2127.79 ± 244.05 pg/ml vs 1568.21 ± 452.06 pg/ml; p < 0.001) in cases than controls. Adiponectin and leptin showed significant variation across BMI and BI-RADS categories in cases. Leptin levels were significantly associated with Modified Bloom-Richardson score and ER/PR receptor status and remained independently associated with breast cancer in multivariate analysis (adjusted OR = 1.005, 95% CI: 1.002–1.009; p = 0.005). ROC analysis demonstrated the superior diagnostic value of leptin (AUC = 0.847; 95% CI: 0.785–0.909; sensitivity 78.7%, specificity 81.3%) over adiponectin. Conclusion: The high adipokine imbalance depicted as low levels of adiponectin and high leptin levels imply their potential as adjunctive biomarkers for identifying the risk of breast cancer in women with MetS.